Ibrutinib for Hospitalized Adults With Severe Coronavirus Disease 2019 Infection: Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study
Coutre et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofac104
https://c19early.org/coutre.html